Literature DB >> 16283195

A review of clinical and histological features of Spanish paediatric medulloblastomas during the last 21 years.

Alejandro Urberuaga1, Aurora Navajas, Juan Burgos, José Ignacio Pijoán.   

Abstract

PURPOSE: To find any feature of prognostic significance among the clinical and histological characteristics of paediatric patients diagnosed with medulloblastoma (MB).
MATERIALS AND METHODS: Clinical charts and paraffin blocks of 79 paediatric patients from nine Spanish institutions diagnosed with MB between 1980 and 2001 were reviewed retrospectively. Included clinical and histological characteristics were age, sex, duration of symptoms, physical signs on admission, tumour location, T and M stages of Chang classification, hydrocephalus, cerebrospinal fluid shunt, surgical resection, complications after surgery, MB subtype, desmoplasia, nodularity, fibrilar pattern, nuclear pleomorphism, necrosis grade, proliferation index and intra-tumoural vascularity. Overall and event-free survival (EFS) univariate and multivariate analyses were assessed.
RESULTS: Type of surgery and necrosis grade appeared to be independent prognostic variables in overall and EFSs. Although nuclear pleomorphism and intra-tumoural vascularity showed a marginally statistical effect on overall survival (OS), both had a significant influence on EFS.
CONCLUSION: We have confirmed surgical resection and added necrosis grade as independent prognostic factors in terms of OS for children diagnosed with MB.

Entities:  

Mesh:

Year:  2005        PMID: 16283195     DOI: 10.1007/s00381-005-0004-4

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  24 in total

1.  Adjuvant chemotherapy for medulloblastoma: the first multi-centre control trial of the International Society of Paediatric Oncology (SIOP I).

Authors:  D M Tait; H Thornton-Jones; H J Bloom; J Lemerle; P Morris-Jones
Journal:  Eur J Cancer       Date:  1990-04       Impact factor: 9.162

2.  Histopathologic grading of medulloblastomas: a Pediatric Oncology Group study.

Authors:  Charles G Eberhart; James L Kepner; Patricia T Goldthwaite; Larry E Kun; Patricia K Duffner; Henry S Friedman; Douglas R Strother; Peter C Burger
Journal:  Cancer       Date:  2002-01-15       Impact factor: 6.860

3.  Duration of symptoms prior to diagnosis is related inversely to presenting disease stage in children with medulloblastoma.

Authors:  E C Halperin; D M Watson; S L George
Journal:  Cancer       Date:  2001-04-15       Impact factor: 6.860

4.  Influence of a child's sex on medulloblastoma outcome.

Authors:  M D Weil; K Lamborn; M S Edwards; W M Wara
Journal:  JAMA       Date:  1998-05-13       Impact factor: 56.272

5.  High microvessel density in primitive neuroectodermal brain tumors of childhood.

Authors:  M A Grotzer; R Wiewrodt; A J Janss; H Zhao; A Cnaan; L N Sutton; L B Rorke; P C Phillips
Journal:  Neuropediatrics       Date:  2001-04       Impact factor: 1.947

6.  Prognostic significance of Ki-67 (MIB-1) proliferation index in childhood primitive neuroectodermal tumors of the central nervous system.

Authors:  M A Grotzer; B Geoerger; A J Janss; H Zhao; L B Rorke; P C Phillips
Journal:  Med Pediatr Oncol       Date:  2001-02

7.  Effects of medulloblastoma resections on outcome in children: a report from the Children's Cancer Group.

Authors:  A L Albright; J H Wisoff; P M Zeltzer; J M Boyett; L B Rorke; P Stanley
Journal:  Neurosurgery       Date:  1996-02       Impact factor: 4.654

8.  Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study.

Authors:  P M Zeltzer; J M Boyett; J L Finlay; A L Albright; L B Rorke; J M Milstein; J C Allen; K R Stevens; P Stanley; H Li; J H Wisoff; J R Geyer; P McGuire-Cullen; J A Stehbens; S B Shurin; R J Packer
Journal:  J Clin Oncol       Date:  1999-03       Impact factor: 44.544

9.  Neuropsychological sequelae of the treatment of children with medulloblastoma.

Authors:  M Dennis; B J Spiegler; C R Hetherington; M L Greenberg
Journal:  J Neurooncol       Date:  1996-07       Impact factor: 4.130

10.  Long-term effects of treatment on endocrine function in children with brain tumors.

Authors:  P K Duffner; M E Cohen; S W Anderson; M L Voorhess; M H MacGillivray; A Panahon; M L Brecher
Journal:  Ann Neurol       Date:  1983-11       Impact factor: 10.422

View more
  6 in total

Review 1.  Evidence in medulloblastomas.

Authors:  A Navajas; J Giralt
Journal:  Clin Transl Oncol       Date:  2010-04       Impact factor: 3.405

2.  Tumor necrosis-initiated complement activation stimulates proliferation of medulloblastoma cells.

Authors:  Adrian J Maurer; Phillip A Bonney; Lucas C Toho; Chad A Glenn; Shweta Agarwal; James D Battiste; Kar-Ming Fung; Michael E Sughrue
Journal:  Inflamm Res       Date:  2015-01-22       Impact factor: 4.575

3.  Medulloblastoma in children: a 32-year experience from a single institution.

Authors:  Canan Akyüz; Ali Varan; Serhan Küpeli; Nejat Akalan; Figen Söylemezoglu; Faruk Zorlu; Tezer Kutluk; Münevver Büyükpamukçu
Journal:  J Neurooncol       Date:  2008-06-20       Impact factor: 4.130

4.  Prognostic impact of semantic MRI features on survival outcomes in molecularly subtyped medulloblastoma.

Authors:  Archya Dasgupta; Tejpal Gupta; Madan Maitre; Babusha Kalra; Abhishek Chatterjee; Rahul Krishnatry; Jayant Sastri Goda; Neelam Shirsat; Sridhar Epari; Ayushi Sahay; Amit Janu; Sona Pungavkar; Girish Chinnaswamy; Vijay Patil; Aliasgar Moiyadi; Prakash Shetty; Rakesh Jalali
Journal:  Strahlenther Onkol       Date:  2022-01-21       Impact factor: 3.621

5.  The impact of provider surgical volumes on survival in children with primary tumors of the central nervous system--a population-based study.

Authors:  Ole Solheim; Øyvind Salvesen; Johan Cappelen; Tom Børge Johannesen
Journal:  Acta Neurochir (Wien)       Date:  2011-03-10       Impact factor: 2.216

6.  Scaling up cancer care for children without medical insurance in developing countries: The case of Mexico.

Authors:  Ricardo Pérez-Cuevas; Svetlana V Doubova; Marta Zapata-Tarres; Sergio Flores-Hernández; Lindsay Frazier; Carlos Rodríguez-Galindo; Gabriel Cortes-Gallo; Salomon Chertorivski-Woldenberg; Onofre Muñoz-Hernández
Journal:  Pediatr Blood Cancer       Date:  2012-08-08       Impact factor: 3.167

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.